Related Experiment Video
Updated: Jul 4, 2026

05:49
Reliability of Artificial Intelligence-Based Cone Beam Computed Tomography Integration with Digital Dental Images
Published on: February 23, 2024
[Research progress in artificial intelligence-driven digital removable partial denture clinical diagnosis and
1Department of Dental Technology, West China Hospital of Stomatology, Sichuan University State Key Laboratory of Oral Diseases National Center for Stomatology National Clinical Research Center for Oral Diseases, Chengdu 610041, China.
Summary
Artificial intelligence (AI) is transforming digital removable partial dentures (RPDs) from simple digital tools to intelligent systems. AI enhances RPD design and clinical decision-making for better patient outcomes.
Area of Science:
- Dentistry
- Prosthodontics
- Artificial Intelligence in Healthcare
Background:
- Digital removable partial denture (RPD) technology has evolved from partial digital substitution to full-process digital intelligent empowerment.
- Initial digital advancements improved efficiency and accuracy but did not fully resolve complex design and clinical outcome challenges.
Purpose of the Study:
- To systematically review the application and efficacy of artificial intelligence (AI) in the digital clinical diagnosis and treatment of RPDs.
- To explore the clinical value and future prospects of AI in advancing RPD prosthodontics.
Main Methods:
- Review of current AI applications in RPD clinical consultation, diagnostic/therapeutic assistance, and RPD design.
- Analysis of AI's integration of expert experience and clinical data for quantitative models.
Main Results:
- AI enables data-driven quantitative models by integrating expert experience and clinical data.
- AI supports clinicians and technicians, advancing RPD restoration towards intelligent decision support.
- AI addresses complex design challenges, moving beyond simple digital substitution.
Conclusions:
- AI represents a significant shift in RPD prosthodontics towards intelligent empowerment.
- AI technology holds substantial clinical value and promising development prospects for RPD treatment.

